TSX lower as gold rally takes a breather
Director Armon Vakili of RYTHM, Inc. (OTC:RYM), a company whose stock has surged over 950% in the past year and currently trades at $39.86, sold 1,900 shares of common stock on September 9, 2025, according to a Form 4 filing with the Securities and Exchange Commission. InvestingPro analysis indicates the stock is currently overvalued based on its Fair Value assessment. The shares were sold at a weighted average price of $38.2277, for a total value of $72,632.
The transactions occurred in multiple sales at prices ranging from $38.00 to $38.50, with the company showing significant price volatility and a market capitalization of approximately $80 million. Following the transaction, Vakili directly owns 8,100 shares of RYTHM, Inc. Get deeper insights into insider trading patterns and 16 additional ProTips with InvestingPro.
In other recent news, Agrify Corporation announced the acquisition of a portfolio of brand intellectual properties from Green Thumb Industries for $50 million. This transaction was financed through a convertible note and includes popular cannabis brands such as RYTHM, Dogwalkers, and Beboe. As part of the agreement, Agrify will license these brands back to Green Thumb Industries for manufacturing and distribution. Additionally, Agrify plans to change its name to RYTHM, Inc. and will begin trading under the new ticker symbol "RYM" on the Nasdaq Capital Market starting September 2, 2025.
In another development, Agrify expanded its stock incentive plan after receiving approval from stockholders during the Annual Meeting. The amendment to the Agrify 2022 Omnibus Equity Incentive Plan increases the number of shares available for issuance by 250,000. This amendment was part of Proposal 3 in the definitive proxy statement filed earlier this year. Detailed information about the plan and its amendment is available in the proxy statement and the company’s current report.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.